Sign inJoin waitlistJoin the waitlist

Andre Goy

Physician · Regional Cancer Care Associates LLC

Credentials: · · ·

History

Regional Cancer Care Associates LLC
Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1995–1997
Internal Medicine
1988–1991
University Sci Et Med De Grenoble, U.e.r. De Med, La Tronche, France
1984–1988

Research

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
The Lancet Oncology · 2019 · 1,921 citations
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · 1,512 citations

Andrew Pecora
33 papers
Tatyana Feldman
33 papers
Brian Hill
26 papers
Andrew Ip
25 papers · 2 as a fellow
Anthony Mato
24 papers
Luis Fayad
23 papers
JR
Jorge Romaguera
22 papers
Barbara Pro
21 papers
PM
Peter Mclaughlin
21 papers
LW
Luhua Wang
19 papers
AY
Anas Younes
18 papers
Maria Rodriguez
18 papers

Clinical trials

A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Principal investigator · Terminated · Phase 1
Hackensack Meridian Health
2017–2020
Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Principal investigator · Active not recruiting · Phase 1
Hackensack Meridian Health
2015–2027
Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
Principal investigator · Completed · Phase 2
Hackensack Meridian Health
2012–2021
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Principal investigator · Terminated · Phase 2
Piramal Enterprises Limited
2009–2012